Home  >  CTSA Cores and Programs > Institutional Career Development (K12) Program

Institutional Career Development (K12) Program

The School of Medicine K12 Mentored Career Development Award provides didactic training, mentoring, and career development to prepare junior faculty for independent careers in translation research. K12 awardees receive advanced training in multiple disciplines, including biostatistics, epidemiology, study design, genetics, bioinformatics, and bioethics. Junior faculty from all health professions in the UTL, MCL, NTLR lines are eligible.

Program Information

K12 Scholar Awardees pursue a mentored research project in their area of expertise. Research performed within the K12 program will provide the basis for an independent NIH award (e.g., K23, K08, or R01).

The K12 award provides salary support up to $120,000 per year (or $106,500 per year for surgical specialities) for two years. For non-surgeons, 75% of the K12 full-time professional effort must be devoted to the K12 program. Exceptions may be made for surgical specialties (e.g., 50% effort). Additional funding of $20,000 per year is available for research expenses and $2,000 per year for travel in support of the objectives of the award.

Program Contacts

Steven Asch, MD, MPH
Faculty Lead

Eleni Linos, MD, MPH, DrPH
Faculty Lead

Ellen Orasa
Program Manager

K12 Scholars

Leandra Barnes, MD
Instructor, Dermatology

Investigating Healthcare Disparities and Patient Perspectives in Hidradenitis Suppurativa: A Mixed-Methods Investigation into Sociodemographic Characteristics, Social Determinants of Health, Treatment Patterns, and Support-seeking Strategies

Hidradenitis suppurativa (HS) is a chronic, painful, disfiguring, and debilitating skin disease, underdiagnosed and disproportionately affecting women and Black Americans. We lack full understanding of the links between sex, race, ethnicity, and social determinants of health (SDOH) with healthcare utilization, treatment, and support for those with HS. We aim to 1) Evaluate the influence of sociodemographic characteristics and SDOH on systemic medication prescriptions, procedures, and clinical visits; and 2) Identify how patients with HS gather information about their disease and seek support, using in-depth qualitative interviews. Using the Epic Cosmos deidentified electronic health record dataset, we will assess associations between sociodemographic and SDOH characteristics and the use of systemic and procedural treatments for HS. Additionally, we will conduct an inductive thematic analysis of 45 in-depth, semi-structured interviews with diverse HS patients to investigate information-gathering behaviors and support systems, assessing sources, reliability, and efficacy. This study will elucidate how sociodemographic and SDOH characteristics influence healthcare use, treatment, and support-seeking behaviors among individuals with HS, to improve the lives of people living with HS, and reduce health disparities.

Talayeh Ghezelayagh, MD, MPH
Instructor, Obstetrics and Gynecology – Gynecologic Oncology

Identifying genomic and epigenomic biomarkers in Pap samples to detect ovarian cancer in patients at high hereditary risks

Patients carrying BRCA1 and BRCA2 germline pathogenic variants (BRCApv) have a 10 to 20-fold elevation in lifetime risk of ovarian cancer (OC) and would benefit from improved screening and risk stratification to help guide decisions regarding preventative surgery. Pap tests can be leveraged as noninvasive liquid biopsies of the reproductive tract with preliminary data suggesting they can be a source of diagnostic biomarkers for OC. This project aims to conduct a pilot case-control study with Pap test DNA from BRCApv patients with and without OC for diagnostic biomarker discovery using DNA methylation and genomic instability analysis. We then aim to prospectively collect additional Pap tests in patients with hereditary cancer syndromes with and without OC for biomarker validation. Analysis of OC data from The Cancer Genome Atlas (TCGA) will also be used to determine differences in epigenomic signatures from patients with and without BRCApv.

Vanessa Kennedy, MD
Assistant Professor, Medicine – Blood and Marrow Transplantation and Cellular Therapy

Treatment Patterns and Allogeneic Transplant Use in Older Adults with Acute Myeloid Leukemia in the Targeted Therapy Era

Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy with greatest incidence in older adults. Although AML can be cured with intensive chemotherapy and allogeneic hematopoietic stem cell transplant (alloHCT), older adults are historically not candidates for these therapies. Over the past five years, less intensive AML therapies have been developed, significantly increasing therapeutic options for older adults. Uptake of these therapies at the population level, as well as barriers to care, remain unknown. With this project, we will identify current treatment patterns and demographic and socioeconomic factors associated with treatment utilization in older adults with AML. We will also estimate the potential gain in life-years should these therapies be utilized more broadly. This study will be conducted using data from the California Cancer Registry, and will include all adults age ≥60 diagnosed with AML from 2014 - 2022. 

Preeti Panda, MD
Assistant Professor, Emergency Medicine – Pediatric Emergency Medicine

Mapping Youth Violence in the United States: Disparities & Links with the Built Environment

Violence is the leading cause of death amongst youth in the United States, and various forms of youth violence (such as physical assault, gun violence, abuse, and child trafficking) overlap in their root causes. Place-based research has shown the built environment and discriminatory policies influence the risk of experiencing community violence, but the effects on multiple forms of youth violence have not been widely explored. We aim to use geospatial mapping to understand how experiences of multiple forms of youth violence are interconnected on both an individual and neighborhood level. We will then use methods of causal inference to 1) Understand how the built environment is linked to risk of and protection from youth violence and 2) Identify mechanisms by which discriminatory housing policies impact the current neighborhood environment and contribute to observed racial and ethnic disparities in experiences of youth violence.